The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Capsule-based Inhalers Market Research Report 2025
Synopsis
Capsule-based inhalers belong to the category of dry powder inhalers and work according to a simple two-step procedure. Capsules are punctured or opened by pressing the device buttons. Then, after inspiration, powder is absorbed into the lung pathway.
The global Capsule-based Inhalers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Capsule-based Inhalers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Capsule-based Inhalers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Capsule-based Inhalers include Hovione, Iconovo AB, Inbrija, Utibron Neohaler (Novartis AG) and Zibo Laixu Medical Equipment, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Capsule-based Inhalers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Capsule-based Inhalers.
Report Scope
The Capsule-based Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Capsule-based Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Capsule-based Inhalers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hovione
Iconovo AB
Inbrija
Utibron Neohaler (Novartis AG)
Zibo Laixu Medical Equipment
Segment by Type
Gelatin Capsules
Hypromellose Capsules
Segment by Application
Asthma
COPD (Chronic Obstructive Pulmonary Disease)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Capsule-based Inhalers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Capsule-based Inhalers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Capsule-based inhalers belong to the category of dry powder inhalers and work according to a simple two-step procedure. Capsules are punctured or opened by pressing the device buttons. Then, after inspiration, powder is absorbed into the lung pathway.
The global Capsule-based Inhalers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Capsule-based Inhalers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Capsule-based Inhalers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Capsule-based Inhalers include Hovione, Iconovo AB, Inbrija, Utibron Neohaler (Novartis AG) and Zibo Laixu Medical Equipment, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Capsule-based Inhalers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Capsule-based Inhalers.
Report Scope
The Capsule-based Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Capsule-based Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Capsule-based Inhalers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hovione
Iconovo AB
Inbrija
Utibron Neohaler (Novartis AG)
Zibo Laixu Medical Equipment
Segment by Type
Gelatin Capsules
Hypromellose Capsules
Segment by Application
Asthma
COPD (Chronic Obstructive Pulmonary Disease)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Capsule-based Inhalers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Capsule-based Inhalers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Capsule-based Inhalers Market Overview
1.1 Product Overview and Scope of Capsule-based Inhalers
1.2 Capsule-based Inhalers Segment by Type
1.2.1 Global Capsule-based Inhalers Market Value Comparison by Type (2024-2030)
1.2.2 Gelatin Capsules
1.2.3 Hypromellose Capsules
1.3 Capsule-based Inhalers Segment by Application
1.3.1 Global Capsule-based Inhalers Market Value by Application: (2024-2030)
1.3.2 Asthma
1.3.3 COPD (Chronic Obstructive Pulmonary Disease)
1.4 Global Capsule-based Inhalers Market Size Estimates and Forecasts
1.4.1 Global Capsule-based Inhalers Revenue 2019-2030
1.4.2 Global Capsule-based Inhalers Sales 2019-2030
1.4.3 Global Capsule-based Inhalers Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Capsule-based Inhalers Market Competition by Manufacturers
2.1 Global Capsule-based Inhalers Sales Market Share by Manufacturers (2019-2024)
2.2 Global Capsule-based Inhalers Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Capsule-based Inhalers Average Price by Manufacturers (2019-2024)
2.4 Global Capsule-based Inhalers Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Capsule-based Inhalers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Capsule-based Inhalers, Product Type & Application
2.7 Capsule-based Inhalers Market Competitive Situation and Trends
2.7.1 Capsule-based Inhalers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Capsule-based Inhalers Players Market Share by Revenue
2.7.3 Global Capsule-based Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Capsule-based Inhalers Retrospective Market Scenario by Region
3.1 Global Capsule-based Inhalers Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Capsule-based Inhalers Global Capsule-based Inhalers Sales by Region: 2019-2030
3.2.1 Global Capsule-based Inhalers Sales by Region: 2019-2024
3.2.2 Global Capsule-based Inhalers Sales by Region: 2025-2030
3.3 Global Capsule-based Inhalers Global Capsule-based Inhalers Revenue by Region: 2019-2030
3.3.1 Global Capsule-based Inhalers Revenue by Region: 2019-2024
3.3.2 Global Capsule-based Inhalers Revenue by Region: 2025-2030
3.4 North America Capsule-based Inhalers Market Facts & Figures by Country
3.4.1 North America Capsule-based Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Capsule-based Inhalers Sales by Country (2019-2030)
3.4.3 North America Capsule-based Inhalers Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Capsule-based Inhalers Market Facts & Figures by Country
3.5.1 Europe Capsule-based Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Capsule-based Inhalers Sales by Country (2019-2030)
3.5.3 Europe Capsule-based Inhalers Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Capsule-based Inhalers Market Facts & Figures by Country
3.6.1 Asia Pacific Capsule-based Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Capsule-based Inhalers Sales by Country (2019-2030)
3.6.3 Asia Pacific Capsule-based Inhalers Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Capsule-based Inhalers Market Facts & Figures by Country
3.7.1 Latin America Capsule-based Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Capsule-based Inhalers Sales by Country (2019-2030)
3.7.3 Latin America Capsule-based Inhalers Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Capsule-based Inhalers Market Facts & Figures by Country
3.8.1 Middle East and Africa Capsule-based Inhalers Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Capsule-based Inhalers Sales by Country (2019-2030)
3.8.3 Middle East and Africa Capsule-based Inhalers Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Capsule-based Inhalers Sales by Type (2019-2030)
4.1.1 Global Capsule-based Inhalers Sales by Type (2019-2024)
4.1.2 Global Capsule-based Inhalers Sales by Type (2025-2030)
4.1.3 Global Capsule-based Inhalers Sales Market Share by Type (2019-2030)
4.2 Global Capsule-based Inhalers Revenue by Type (2019-2030)
4.2.1 Global Capsule-based Inhalers Revenue by Type (2019-2024)
4.2.2 Global Capsule-based Inhalers Revenue by Type (2025-2030)
4.2.3 Global Capsule-based Inhalers Revenue Market Share by Type (2019-2030)
4.3 Global Capsule-based Inhalers Price by Type (2019-2030)
5 Segment by Application
5.1 Global Capsule-based Inhalers Sales by Application (2019-2030)
5.1.1 Global Capsule-based Inhalers Sales by Application (2019-2024)
5.1.2 Global Capsule-based Inhalers Sales by Application (2025-2030)
5.1.3 Global Capsule-based Inhalers Sales Market Share by Application (2019-2030)
5.2 Global Capsule-based Inhalers Revenue by Application (2019-2030)
5.2.1 Global Capsule-based Inhalers Revenue by Application (2019-2024)
5.2.2 Global Capsule-based Inhalers Revenue by Application (2025-2030)
5.2.3 Global Capsule-based Inhalers Revenue Market Share by Application (2019-2030)
5.3 Global Capsule-based Inhalers Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hovione
6.1.1 Hovione Corporation Information
6.1.2 Hovione Description and Business Overview
6.1.3 Hovione Capsule-based Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hovione Capsule-based Inhalers Product Portfolio
6.1.5 Hovione Recent Developments/Updates
6.2 Iconovo AB
6.2.1 Iconovo AB Corporation Information
6.2.2 Iconovo AB Description and Business Overview
6.2.3 Iconovo AB Capsule-based Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Iconovo AB Capsule-based Inhalers Product Portfolio
6.2.5 Iconovo AB Recent Developments/Updates
6.3 Inbrija
6.3.1 Inbrija Corporation Information
6.3.2 Inbrija Description and Business Overview
6.3.3 Inbrija Capsule-based Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Inbrija Capsule-based Inhalers Product Portfolio
6.3.5 Inbrija Recent Developments/Updates
6.4 Utibron Neohaler (Novartis AG)
6.4.1 Utibron Neohaler (Novartis AG) Corporation Information
6.4.2 Utibron Neohaler (Novartis AG) Description and Business Overview
6.4.3 Utibron Neohaler (Novartis AG) Capsule-based Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Utibron Neohaler (Novartis AG) Capsule-based Inhalers Product Portfolio
6.4.5 Utibron Neohaler (Novartis AG) Recent Developments/Updates
6.5 Zibo Laixu Medical Equipment
6.5.1 Zibo Laixu Medical Equipment Corporation Information
6.5.2 Zibo Laixu Medical Equipment Description and Business Overview
6.5.3 Zibo Laixu Medical Equipment Capsule-based Inhalers Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zibo Laixu Medical Equipment Capsule-based Inhalers Product Portfolio
6.5.5 Zibo Laixu Medical Equipment Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Capsule-based Inhalers Industry Chain Analysis
7.2 Capsule-based Inhalers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Capsule-based Inhalers Production Mode & Process
7.4 Capsule-based Inhalers Sales and Marketing
7.4.1 Capsule-based Inhalers Sales Channels
7.4.2 Capsule-based Inhalers Distributors
7.5 Capsule-based Inhalers Customers
8 Capsule-based Inhalers Market Dynamics
8.1 Capsule-based Inhalers Industry Trends
8.2 Capsule-based Inhalers Market Drivers
8.3 Capsule-based Inhalers Market Challenges
8.4 Capsule-based Inhalers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
